PillRx only · Injection · Intravenous
Heparin Sodium
Heparin Sodium
11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US40 NDCs
11 active makers
11 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$2.965
Latest avg · Jul 22, 2026
-61%
Since Jul 23, 2025
11
Active US suppliers
53%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
31K
Rx · 2026 Q1
243K
Units dispensed
-41%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it11 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Meitheal Pharmaceuticals Inc. | unknown | 12 | SUPPLYING |
| NorthStar RxLLC | unknown | 8 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 5 | SUPPLYING |
| Gland Pharma Limited | unknown | 3 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 2 | SUPPLYING |
| Civica, Inc. | unknown | 2 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 2 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 1 | SUPPLYING |
| Plano Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
| Pfizer Laboratories Div Pfizer Inc | unknown | 1 | SUPPLYING |
| Mylan Institutional LLC | unknown | 6 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 28, 2023RECALLRecall (Class II): Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcuta…
Labeling: Not elsewhere classified — Recalling firm: Sagent Pharmaceuticals Inc — USA Nationwide